Patents by Inventor Edward P. Ingenito
Edward P. Ingenito has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9999701Abstract: One aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant nucleophilic groups and a crosslinker comprising at least two pendant electrophilic groups. Another aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant electrophilic groups and a crosslinker comprising at least two pendant nucleophilic groups. Yet another aspect of the invention relates to a method for reducing lung volume in a patient comprising the step of administering a hydrogel composition as described herein. Further, hydrogels of the invention may be used to achieve pleurodesis, seal brochopleural fistulas, seal an air leak in a lung, achieve hemostasis, tissue sealing (e.g., blood vessels, internal organs), or any combination thereof. In certain embodiments, the compositions and methods described herein are intended for use in the treatment of patients with emphysema.Type: GrantFiled: February 6, 2017Date of Patent: June 19, 2018Assignee: Pulmonx CorporationInventors: Edward P. Ingenito, James A. Krom, Alexander Schwarz, Larry W. Tsai
-
Publication number: 20170239385Abstract: One aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant nucleophilic groups and a crosslinker comprising at least two pendant electrophilic groups. Another aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant electrophilic groups and a crosslinker comprising at least two pendant nucleophilic groups. Yet another aspect of the invention relates to a method for reducing lung volume in a patient comprising the step of administering a hydrogel composition as described herein. Further, hydrogels of the invention may be used to achieve pleurodesis, seal brochopleural fistulas, seal an air leak in a lung, achieve hemostasis, tissue sealing (e.g., blood vessels, internal organs), or any combination thereof. In certain embodiments, the compositions and methods described herein are intended for use in the treatment of patients with emphysema.Type: ApplicationFiled: February 6, 2017Publication date: August 24, 2017Inventors: Edward P. Ingenito, James A. Krom, Alexander Schwarz, Larry W. Tsai
-
Patent number: 9561301Abstract: One aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant nucleophilic groups and a crosslinker comprising at least two pendant electrophilic groups. Another aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant electrophilic groups and a crosslinker comprising at least two pendant nucleophilic groups. Yet another aspect of the invention relates to a method for reducing lung volume in a patient comprising the step of administering a hydrogel composition as described herein. Further, hydrogels of the invention may be used to achieve pleurodesis, seal brochopleural fistulas, seal an air leak in a lung, achieve hemostasis, tissue sealing (e.g., blood vessels, internal organs), or any combination thereof. In certain embodiments, the compositions and methods described herein are intended for use in the treatment of patients with emphysema.Type: GrantFiled: April 14, 2015Date of Patent: February 7, 2017Assignee: Aeris Therapeutics, LLCInventors: Edward P. Ingenito, James A. Krom, Alexander Schwarz, Larry W. Tsai
-
Publication number: 20150217020Abstract: One aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant nucleophilic groups and a crosslinker comprising at least two pendant electrophilic groups. Another aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant electrophilic groups and a crosslinker comprising at least two pendant nucleophilic groups. Yet another aspect of the invention relates to a method for reducing lung volume in a patient comprising the step of administering a hydrogel composition as described herein. Further, hydrogels of the invention may be used to achieve pleurodesis, seal brochopleural fistulas, seal an air leak in a lung, achieve hemostasis, tissue sealing (e.g., blood vessels, internal organs), or any combination thereof. In certain embodiments, the compositions and methods described herein are intended for use in the treatment of patients with emphysema.Type: ApplicationFiled: April 14, 2015Publication date: August 6, 2015Inventors: Edward P. Ingenito, James A. Krom, Alexander Schwarz, Larry W. Tsai
-
Publication number: 20150196682Abstract: One aspect of the present invention relates to bronchoscopic lung volume reduction using solutions of biopolymers that can be polymerized in situ with a crosslinker and a polymeric additive which accelerates the cross-linking reaction. In certain embodiments, the biopolymer solutions can be in the form of a foam or gel. The biopolymer compositions disclosed herein may also be used for indications other than lung volume reduction, such as sealing fistulas or performing emergency tamponade of vessels.Type: ApplicationFiled: December 16, 2014Publication date: July 16, 2015Inventors: Larry W. Tsai, Edward P. Ingenito
-
Patent number: 9006340Abstract: One aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant nucleophilic groups and a crosslinker comprising at least two pendant electrophilic groups. Another aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant electrophilic groups and a crosslinker comprising at least two pendant nucleophilic groups. Yet another aspect of the invention relates to a method for reducing lung volume in a patient comprising the step of administering a hydrogel composition as described herein. Further, hydrogels of the invention may be used to achieve pleurodesis, seal brochopleural fistulas, seal an air leak in a lung, achieve hemostasis, tissue sealing (e.g., blood vessels, internal organs), or any combination thereof. In certain embodiments, the compositions and methods described herein are intended for use in the treatment of patients with emphysema.Type: GrantFiled: May 21, 2013Date of Patent: April 14, 2015Assignee: Aeris Therapeutics, LLCInventors: Edward P. Ingenito, James A. Krom, Alexander Schwarz, Larry W. Tsai
-
Patent number: 8911750Abstract: One aspect of the present invention relates to bronchoscopic lung volume reduction using solutions of biopolymers that can be polymerized in situ with a crosslinker and a polymeric additive which accelerates the cross-linking reaction. In certain embodiments, the biopolymer solutions can be in the form of a foam or gel. The biopolymer compositions disclosed herein may also be used for indications other than lung volume reduction, such as sealing fistulas or performing emergency tamponade of vessels.Type: GrantFiled: April 3, 2008Date of Patent: December 16, 2014Inventors: Larry W. Tsai, Edward P. Ingenito
-
Publication number: 20130325061Abstract: One aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant nucleophilic groups and a crosslinker comprising at least two pendant electrophilic groups. Another aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant electrophilic groups and a crosslinker comprising at least two pendant nucleophilic groups. Yet another aspect of the invention relates to a method for reducing lung volume in a patient comprising the step of administering a hydrogel composition as described herein. Further, hydrogels of the invention may be used to achieve pleurodesis, seal brochopleural fistulas, seal an air leak in a lung, achieve hemostasis, tissue sealing (e.g., blood vessels, internal organs), or any combination thereof. In certain embodiments, the compositions and methods described herein are intended for use in the treatment of patients with emphysema.Type: ApplicationFiled: May 21, 2013Publication date: December 5, 2013Applicant: Aeris Therapeutics, LLCInventors: Edward P. Ingenito, James A. Krom, Alexander Schwarz, Larry W. Tsai
-
Patent number: 8445589Abstract: One aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant nucleophilic groups and a crosslinker comprising at least two pendant electrophilic groups. Another aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant electrophilic groups and a crosslinker comprising at least two pendant nucleophilic groups. Yet another aspect of the invention relates to a method for reducing lung volume in a patient comprising the step of administering a hydrogel composition as described herein. Further, hydrogels of the invention may be used to achieve pleurodesis, seal brochopleural fistulas, seal an air leak in a lung, achieve hemostasis, tissue sealing (e.g., blood vessels, internal organs), or any combination thereof. In certain embodiments, the compositions and methods described herein are intended for use in the treatment of patients with emphysema.Type: GrantFiled: June 11, 2012Date of Patent: May 21, 2013Assignee: Aeris Therapeutics, LLCInventors: Edward P. Ingenito, James A. Krom, Alexander Schwarz, Larry W. Tsai
-
Patent number: 8361484Abstract: One aspect of the invention relates to a hydrogel comprising a polymer comprising a plurality of pendent hydroxyl groups, a crosslinker, and a sclerosing agent. Another aspect of the invention relates to a method for reducing lung volume in a patient comprising the steps of advancing into a region of a patient's lung via said patient's trachea a multi-lumen catheter lumen through a bronchoscope; and co-administering, through the multi-lumen catheter, a first mixture comprising a first amount of a polymer containing a plurality of pendent hydroxyl groups; a second mixture comprising a second amount of a crosslinker; and a third mixture comprising a third amount of a sclerosing agent; thereby forming a hydrogel in said region. In certain embodiments, the compositions and methods described herein are intended for use in the treatment of patients with emphysema of the lung.Type: GrantFiled: September 27, 2007Date of Patent: January 29, 2013Assignee: Aeris Therapeutics, Inc.Inventors: Edward P. Ingenito, Alexander Schwarz, Larry W. Tsai
-
Publication number: 20120245627Abstract: One aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant nucleophilic groups and a crosslinker comprising at least two pendant electrophilic groups. Another aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant electrophilic groups and a crosslinker comprising at least two pendant nucleophilic groups. Yet another aspect of the invention relates to a method for reducing lung volume in a patient comprising the step of administering a hydrogel composition as described herein. Further, hydrogels of the invention may be used to achieve pleurodesis, seal brochopleural fistulas, seal an air leak in a lung, achieve hemostasis, tissue sealing (e.g., blood vessels, internal organs), or any combination thereof. In certain embodiments, the compositions and methods described herein are intended for use in the treatment of patients with emphysema.Type: ApplicationFiled: June 11, 2012Publication date: September 27, 2012Applicant: AERIS THERAPEUTICS, INC.Inventors: Edward P. Ingenito, James A. Krom, Alexander Schwarz, Larry W. Tsai
-
Patent number: 8198365Abstract: One aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant nucleophilic groups and a crosslinker comprising at least two pendant electrophilic groups. Another aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant electrophilic groups and a crosslinker comprising at least two pendant nucleophilic groups. Yet another aspect of the invention relates to a method for reducing lung volume in a patient comprising the step of administering a hydrogel composition as described herein. Further, hydrogels of the invention may be used to achieve pleurodesis, seal brochopleural fistulas, seal an air leak in a lung, achieve hemostasis, tissue sealing (e.g., blood vessels, internal organs), or any combination thereof. In certain embodiments, the compositions and methods described herein are intended for use in the treatment of patients with emphysema.Type: GrantFiled: May 8, 2008Date of Patent: June 12, 2012Assignee: Aeris Therapeutics, LLCInventors: Edward P. Ingenito, James A. Krom, Alexander Schwarz, Larry W. Tsai
-
Patent number: 7861710Abstract: A hand-held apparatus that delivers pressurized breathing gas to the airway of a patient, thereby creating positive end expiratory pressure (PEEP) and reducing respiratory muscle fatigue. The apparatus includes a deformable reservoir, a breathing interface, and a pressure relief valve. The apparatus may include a means for creating fluid communication between the deformable reservoir and a source of pressurized breathing gas. The apparatus may also include an adjuster that allows a user to vary the pressure of the breathing gas contained in the deformable reservoir.Type: GrantFiled: July 2, 2007Date of Patent: January 4, 2011Assignee: Aeris Therapeutics, Inc.Inventor: Edward P. Ingenito
-
Patent number: 7819908Abstract: The invention includes a method for performing non-surgical lung volume reduction in a patient by applying an amount of energy with a catheter to a diseased alveolar region of the lung of a patient having emphysema, wherein the amount of energy is sufficient to damage the epithelial cells and the epithelial barrier within the diseased alveolar region of the lung and collapse at least a portion of said region thereby reducing the lung volume, and wherein the energy comprises thermal energy, electrical energy, and ultrasonic energy.Type: GrantFiled: December 17, 2004Date of Patent: October 26, 2010Assignee: Aeris Therapeutics, Inc.Inventor: Edward P. Ingenito
-
Publication number: 20100040538Abstract: One aspect of the invention relates to a hydrogel comprising a polymer comprising a plurality of pendent hydroxyl groups, a crosslinker, and a sclerosing agent. Another aspect of the invention relates to a method for reducing lung volume in a patient comprising the steps of advancing into a region of a patient's lung via said patient's trachea a multi-lumen catheter lumen through a bronchoscope; and co-administering, through the multi-lumen catheter, a first mixture comprising a first amount of a polymer containing a plurality of pendent hydroxyl groups; a second mixture comprising a second amount of a crosslinker; and a third mixture comprising a third amount of a sclerosing agent; thereby forming a hydrogel in said region. In certain embodiments, the compositions and methods described herein are intended for use in the treatment of patients with emphysema of the lung.Type: ApplicationFiled: September 26, 2007Publication date: February 18, 2010Inventors: Edward P. Ingenito, Alexander Schwarz, Larry W. Tsai
-
Patent number: 7654999Abstract: Devices, compositions, and methods for achieving non-surgical lung volume reduction (e.g., bronchoscopic lung volume reduction (BLVR)) are described. BLVR can be carried out by collapsing a region of the lung, adhering one portion of the collapsed region to another, and promoting fibrosis in or around the adherent tissue.Type: GrantFiled: August 26, 2003Date of Patent: February 2, 2010Assignee: Aeris Therapeutics, Inc.Inventor: Edward P. Ingenito
-
Publication number: 20080281352Abstract: One aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant nucleophilic groups and a crosslinker comprising at least two pendant electrophilic groups. Another aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant electrophilic groups and a crosslinker comprising at least two pendant nucleophilic groups. Yet another aspect of the invention relates to a method for reducing lung volume in a patient comprising the step of administering a hydrogel composition as described herein. Further, hydrogels of the invention may be used to achieve pleurodesis, seal brochopleural fistulas, seal an air leak in a lung, achieve hemostasis, tissue sealing (e.g., blood vessels, internal organs), or any combination thereof. In certain embodiments, the compositions and methods described herein are intended for use in the treatment of patients with emphysema.Type: ApplicationFiled: May 8, 2008Publication date: November 13, 2008Applicant: AERIS THERAPEUTICS, INC.Inventors: Edward P. Ingenito, James A. Krom, Alexander Schwarz, Larry W. Tsai
-
Publication number: 20080261884Abstract: One aspect of the present invention relates to bronchoscopic lung volume reduction using solutions of biopolymers that can be polymerized in situ with a crosslinker and a polymeric additive which accelerates the cross-linking reaction. In certain embodiments, the biopolymer solutions can be in the form of a foam or gel. The biopolymer compositions disclosed herein may also be used for indications other than lung volume reduction, such as sealing fistulas or performing emergency tamponade of vessels.Type: ApplicationFiled: April 3, 2008Publication date: October 23, 2008Applicant: AERIS THERAPEUTICS, INC.Inventors: Larry W. Tsai, Edward P. Ingenito
-
Publication number: 20080115787Abstract: A hand-held apparatus that delivers pressurized breathing gas to the airway of a patient, thereby creating positive end expiratory pressure (PEEP) and reducing respiratory muscle fatigue. The apparatus includes a deformable reservoir, a breathing interface, and a pressure relief valve. The apparatus may include a means for creating fluid communication between the deformable reservoir and a source of pressurized breathing gas. The apparatus may also include an adjuster that allows a user to vary the pressure of the breathing gas contained in the deformable reservoir.Type: ApplicationFiled: July 2, 2007Publication date: May 22, 2008Applicant: Aeris TherapeuticsInventor: Edward P. Ingenito
-
Patent number: 7300428Abstract: Devices, compositions, and methods for achieving non-surgical lung volume reduction (e.g., bronchoscopic lung volume reduction (BLVR)) are described. BLVR can be carried out by collapsing a region of the lung, adhering one portion of the collapsed region to another, and promoting fibrosis in or around the adherent tissue.Type: GrantFiled: December 11, 2004Date of Patent: November 27, 2007Assignee: Aeris Therapeutics, Inc.Inventor: Edward P. Ingenito